IMMU

Search by
TICKER SYMBOL

OptionsHawk Content

M&A Analysis – Biotech – Oncology – October 2020

Oct 01, 2020

Immunomedic (IMMU) a notable deal in Biotech at a value of $21B and coming at a sizable 108% premium from Gilead (GILD) with M&A in...

read more

IMMU Calls (2-19)

Feb 19, 2020

read more

M&A Analysis: Biotech M&A – July 2019

Jul 01, 2019

The Pfizer (PFE) deal for Array (ARRY) was one of the most interesting deals as it came at a strong 60% premium and options activity...

read more